Elicio Therapeutics (ELTX) Asset Utilization Ratio (2021 - 2023)

Elicio Therapeutics (ELTX) has reported Asset Utilization Ratio for 3 consecutive years, with 0.02 the latest figure, recorded in Q1 2023.

• For the quarter ending Q1 2023, Asset Utilization Ratio fell 93.91% year-over-year to 0.02; the trailing twelve-month figure through Mar 2023 stood at 0.02 (down 93.91% YoY), and the FY2022 full-year result was 0.04, down 90.19% from the prior year.
• Asset Utilization Ratio fell to 0.02 in Q1 2023 per ELTX's latest filing, from 0.05 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.43 in Q3 2022 and bottomed at 0.02 in Q2 2021.
• Historically, Asset Utilization Ratio has averaged 0.17 across 3 years, with a median of 0.05 in 2022.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio surged 2251.97% in 2022, then sank 93.91% in 2023.
• Over 3 years, Asset Utilization Ratio stood at 0.27 in 2021, then slumped by 80.02% to 0.05 in 2022, then sank by 63.01% to 0.02 in 2023.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.05, and 0.43 for Q1 2023, Q4 2022, and Q3 2022 respectively.